Latest news with #Topaz
Business Upturn
2 days ago
- Business
- Business Upturn
Stocks to watch on May 30: Suzlon, EIL, Sobha, NBCC, Infosys, Bajaj Auto, Wipro in focus after Q4 results, deal wins
Indian equities will track a busy slate of stock-specific developments today, with several key companies reporting quarterly results and announcing fresh deals. Suzlon, Engineers India (EIL), Sobha, NBCC, Infosys, Bajaj Auto, and Wipro are among the stocks in focus following their Q4 earnings and business updates. Strong earnings boost stocks Suzlon Energy reported a strong Q4 with net profit surging to ₹1,181 crore from ₹254 crore a year ago, while revenue climbed to ₹3,774 crore from ₹2,179 crore. Engineers India (EIL) posted net profit of ₹280 crore versus ₹115 crore YoY, with revenue rising to ₹1,010 crore. Sobha Ltd saw net profit jump to ₹40.8 crore from ₹7 crore, while revenue surged to ₹1,240.6 crore. NBCC also delivered solid results with net profit of ₹176 crore versus ₹136 crore and revenue at ₹4,642 crore versus ₹3,996 crore. IT majors: Infosys, Wipro in news Infosys launched over 200 enterprise AI agents as part of its Topaz AI offerings in collaboration with Google Cloud. The company is also trading ex-dividend today (₹22 per share). Wipro unveiled its 'Wipro Innovation Network,' targeting frontier technologies such as AI and quantum computing. Bajaj Auto, other key movers Bajaj Auto reported neutral results with net profit of ₹1,801.85 crore versus ₹2,011.43 crore and revenue of ₹12,646 crore versus ₹11,554 crore. Other notable earnings include ICRA, Lumax Auto, Technocraft, Lemon Tree Hotels, Yatra, Antony Waste, SENCO, Procter & Gamble Health, and Orchid Pharma, all posting positive YoY growth. New orders, partnerships NLC India signed a JV agreement with Mahatma Phule Renewable Energy and Infrastructure Technology Ltd. Frontier Springs secured ₹292.6 crore worth of orders from Indian Railways' coach factories. Vakrangee's unit received an LOI from Punjab & Sind Bank for supply and maintenance of 600 ATMs. Stocks facing headwinds In the red, Ola Electric posted a larger net loss of ₹870 crore, compared to ₹416 crore YoY, with revenue also sharply down. Vishnu Prakash R Punglia, KNR Constructions, SJVN, Mazdock, Shalby, TARC, and Landmark Cars also reported weaker earnings. Wardwizard saw promoter Yatin Sanjay Gupte offload 64.5 lakh shares between May 21-27, adding to selling pressure. F&O, corporate actions Stocks being added to F&O segment from today include RVNL, BDL, Bluestar, Fortis, Kaynes, Mankind, PPL Pharma, and Uno Minda. Several stocks, including Infosys, Bajaj Finance, Angel One, Glaxosmithkline, and others, will trade ex-dividend today. Disclaimer: The above article is purely based on company filings and public sources. Business Upturn does not provide investment advice. Investors are advised to consult certified professionals before making investment decisions. News desk at
Business Upturn
2 days ago
- Business
- Business Upturn
Top stocks to watch today, May 30: Bajaj Auto, Mazagon Dock, Suzlon Energy, NBCC, Ola Electric and more
By Aman Shukla Published on May 30, 2025, 08:29 IST Indian equity benchmarks ended higher on Thursday, driven by positive global cues, despite headwinds from rising bond yields and crude oil prices. The BSE Sensex rose 320.70 points (0.39%) to close at 81,633.02, while the NSE Nifty50 gained 81.15 points (0.33%) to settle at 24,833.60. As the markets look to close the week, several stocks are expected to remain in focus on Friday, May 30, 2025, based on recent earnings updates, partnerships, and operational developments. Key Stocks to Watch Bajaj Auto Reported stable Q4 earnings with operating margins exceeding 20% for the sixth consecutive quarter. Infosys Announced the launch of over 200 enterprise AI agents as part of its Topaz AI offerings, in collaboration with Google Cloud. Lemon Tree Hotels EBITDA increased by 19% year-on-year (YoY), with margins improving to 53.90% from 52.40%. Samhi Hotels Margins rose to 38% from 30.60%, with a 42.20% YoY increase in EBITDA. Suzlon Energy EBITDA nearly doubled, rising 94% YoY, with margins improving to 18.40% from 16.40%. Prestige Estates Projected FY26 gross development value to be 61% higher compared to the previous year. Sobha Ltd Reported a 63% YoY increase in Q4 revenue and a 52% rise in EBITDA. NLC India Its subsidiary signed a joint venture agreement with MAHAPREIT to undertake renewable energy projects in Maharashtra. P&G Health EBITDA grew 20.20%, and revenue rose by 23.20% YoY. NBCC Reported a 19.30% increase in EBITDA, with a slight margin improvement to 6.25% from 6.09%. Texmaco Rail & Engineering Entered an MoU with RVNL to collaborate in various areas of mutual interest. Concord Biotech EBITDA increased 42% YoY, with margins improving to 44.30% from 42.07%. Hexaware Announced a partnership with to integrate voice AI into enterprise operations. Senco Gold EBITDA rose by 45% YoY, with margins improving to 9.20% from 7.68%. Mazagon Dock Shipbuilders Reported an 83% decline in EBITDA; margins dropped to 2.84% from 16.89%. Ola Electric Q4 results reflected operational weakness, with widening losses on both QoQ and YoY bases. Amara Raja Energy & Mobility EBITDA declined by 17%, and margins contracted to 11.1% from 14.1%. SJVN Q4 power generation fell by 4%, with margins decreasing to 47.70% from 49.70% YoY. Welspun Living Reported a 12% drop in EBITDA, with margins at 11.94% compared to 13.93% YoY. Bectors Food EBITDA declined 5%, and margins narrowed to 12.44% from 14.40%. Landmark Cars Revenue dropped 87%, with margins declining to 4.99% from 6.18% YoY. KNR Construction EBITDA fell 40.80% YoY, and margins slipped to 22.73% from 26.46%. Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information. Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at
Business Upturn
3 days ago
- Business
- Business Upturn
Infosys launches over 200 enterprise AI agents to transform enterprise workflows
Infosys has launched over 200 enterprise AI agents powered by Infosys TopazTM AI offerings and Google Cloud's Vertex AI Platform. These AI agents are part of the Infosys Topaz offerings and are intended to simplify complex workflows and support large-scale business operations across various industries. The AI agents serve multiple sectors, including healthcare, finance, retail, telecom, manufacturing, and agriculture. They are built to manage diverse and often unstructured data through advanced machine learning and cognitive capabilities. Key functions include extracting useful information from raw data and supporting multimodal data processing, allowing them to work with text, images, and other input types. Security and data privacy are embedded in their design, with encrypted communication channels and compliance measures aimed at protecting sensitive enterprise information. One of the notable aspects of these AI agents is their ability to make decisions autonomously. This allows businesses to automate parts of their operations, reducing the need for manual oversight in many routine or complex tasks. In practice, these agents are being applied in several business scenarios. In network operations, for example, they help monitor network capacity in real time, which can reduce downtime and improve service reliability. In corporate finance, they support tasks like managing payables and receivables, contributing to more accurate financial tracking and improved cash flow management. In manufacturing, the AI agents assist in demand forecasting for components, helping streamline inventory and supply chain processes. The launch represents a step toward more scalable AI integration in enterprise settings, with a focus on practical use cases and measurable outcomes. Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at
Yahoo
5 days ago
- Business
- Yahoo
Infosys and E.ON Join Forces to Develop AI-Powered Digital Workplaces
Infosys Ltd's (NYSE:INFY) artificial intelligence solutions continue to elicit strong interest in the market. That was clear on May 27, as the digital services and consulting company inked a strategic partnership with Germany's The two companies are joining forces to create an experience-led, data-driven, and sustainability-focused digital workplace ecosystem. A scientist at a computer station, surrounded by a neural network of artificial intelligence code. is to leverage Infosys AI's first offering, Topaz, to modernize its operations and enhance user value. The generative AI solution is also expected to accelerate transition into a full-stack digital energy company. Infosys is committed to ensuring that energy networks and infrastructure companies realize business value through artificial intelligence. The strategic partnership with Infosys is key to digital transformation as it seeks to enable a brighter, more efficient energy future. Infosys is committed to enshrining its generative AI system. Topaz enables an AI-powered digital workplace transformation to bolster productivity and employee experience. The Indian IT giant has carved a niche as a global leader in next-generation digital services, leveraging advanced technology such as artificial intelligence. Infosys is a leader in digital services and consulting, helping businesses in 56+ countries accelerate AI-driven transformation. Committed to sustainability, governance, and diversity, the company fosters continuous growth through digital skills and agile solutions. While we acknowledge the potential of Infosys Ltd (NYSE:INFY) as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than INFY and that has 100x upside potential, check out our report about the cheapest AI stock. READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires. Disclosure: None.
Yahoo
22-05-2025
- Health
- Yahoo
TRiCares presents promising First-In-Human Topaz data at EuroPCR 2025
Early results demonstrate near-complete elimination of tricuspid regurgitation in implanted patients with favorable safety profile and no permanent pacemaker implantations Paris, France and Munich, Germany, 22 May, 2025 – TRiCares SAS ('TRiCares'), a privately held pioneer in the field of minimally invasive treatment of tricuspid regurgitation, is presenting data in a late-breaking session at EuroPCR today from its first-in-human trial of Topaz, its Transcatheter Tricuspid Valve Replacement (TTVR) system. Today, Dr Julien Dreyfus, MD, PhD will present 30-day post-procedural data from 20 tricuspid regurgitation (TR) patients treated with Topaz across eight specialist cardiac centers in Europe. The TRICURE First-In-Human study demonstrated significant elimination of TR in treated patients, with grade 'none' (0+) or 'mild' (1+) TR reported in all patients implanted with Topaz. In addition, zero permanent pacemakers were required due to the investigational device. The implantation procedure lasted, on average, 35 minutes. These early clinical results from Topaz compare favorably with existing TTVR treatment approaches, with a procedure that is fast, easy-to-use, and less demanding of imaging specialists. Further details on the data will be shared in today's oral presentation at EuroPCR 2025 and on 'We are highly encouraged by the results of this first-in-human trial. These initial findings serve as important validation for our ongoing clinical trials for Topaz in Europe and the US,' said Ahmed Elmouelhi, President & CEO of TRiCares. 'I want to extend our sincere gratitude to the participating hospitals, the dedicated interventional teams and clinical investigators who contributed to these patient outcomes. To date, the TRiCares team has overseen 60 Topaz implantations, and we continue to work closely with clinicians to refine the procedure and technique.' The initial findings will be used to inform the company's ongoing European pivotal trial (NCT06581471) and U.S. Early Feasibility Study (NCT06506942). EuroPCR presentation details Session: Tricuspid hotline: new devices Title: TRiCares Topaz transfemoral TRICUspid heart valve REplacement system first-in-human trial Presenter: Julien Dreyfus, MD, PhD, FESC, Cardiologist at Centre Cardiologique du Nord, Saint-Denis, France Location: Theatre Bordeaux Date/time: Thursday, 22 May 2025, 08:30 – 09:30 CEST About TRiCaresTRiCares is a privately held company developing Topaz, a minimally invasive tricuspid valve replacement system for the elimination of tricuspid regurgitation (TR). Topaz's unique dual stent design is easy to implant and uses established transfemoral and transjugular delivery methods, avoiding the need for high-risk open-heart surgery. Topaz is designed to fit a wide range of anatomies and replaces the diseased tricuspid valve. Once in place, it flexes with every heartbeat. A European Pivotal Study and a US/Canadian Early Feasibility Study are underway, with progress being made towards FDA approval and CE marking. TRiCares has focused on TR since its inception and its ambition is for Topaz to become the valve of choice for the millions of TR patients worldwide, overcoming the limitations of current treatment approaches. TRiCares is a global business, with offices in France, Germany, the US and Brazil, and is supported by a strategic partner and leading life science venture capital firms: 415 Capital, Andera Partners, Bayern Kapital, BioMed Partners, Credit Mutuel Innovation, GoCapital, Karista, and Wellington Partners. About TopazThe Topaz Transcatheter Tricuspid Valve Replacement (TTVR) System is designed to eliminate tricuspid regurgitation through a minimally invasive approach. This system consists of the Topaz Heart Valve Prosthesis and a catheter-based implantation system. It is developed exclusively for use in the tricuspid position and to provide a system for physicians that is safe and easy to implant. The unique two-stent valve prosthesis is inserted primarily via the femoral vein and transports the prosthesis into the right side of the heart, where it is finally released to replace the diseased tricuspid valve. For further information please contact: TRiCares SASAhmed Elmouelhi, President & CEOinfo@ ICR Healthcare Lucy FeatherstoneT: +44 (0)20 3709 5700tricares@ in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
